Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than originally ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

Humana (HUM) stock jumps as the company with its Q2 results lifts its 2025 outlook, citing strength in its Medicare Advantage ...

Humana raised its annual profit forecast after beating quarterly estimates on Wednesday, as the U.S. health insurer succeeded ...

Humana is raising its full-year guidance after surpassing revenue expectations in the second quarter, the insurer announced ...

Humana raises its annual profit forecast to $17 per share, citing stabilized medical costs and better-than-expected ...

Humana beat Q2 EPS and revenue estimates and raised its 2025 outlook, driven by strong PDP growth and higher CenterWell ...

Humana’s worsening fortunes have been a bellwether for the industry, as it has struggled with rising medical costs and ...

Only a few days after a federal judge struck down Humana’s lawsuit challenging the Medicare Advantage star ratings system, ...

Humana lowered its full-year 2025 GAAP EPS guidance to approximately $13.77, down from $14.68. At the same time, it raised ...

Humana is taking a second bite at the apple to improve its sunken MA stars, filing an edited complaint with a Texas court on ...

Humana's growth trajectory could rebound from current weakness, with management calling for pretax profits to more than double from 2025 to 2028 and grow in the low double digits in the long run at ...